Cipla gets 2 observations after USFDA Goa plant inspection, says will address concerns
Cipla Limited said on Friday, April 17 that the US Food and Drug Administration (USFDA) conducted an inspection at its manufacturing facility in Verna, Goa, from April 6 to April 17, 2026. The inspection comprised a routine current Good Manufacturing Practices (cGMP) review along with a Pre-Approval Inspection (PAI), the company said in a regulatory…
